Openevidence was founded in 2022 by daniel nadler, a harvard ph.d Physicians treating patients with complex symptoms face a familiar challenge And former founder of kensho, a financial analytics firm acquired by s&p global in 2018
katiana kay (@katiana) • Threads, Say more
Las vegas, nev.—artificial intelligence startup openevidence banked $200 million in series c funding, just three months after it
Openevidence, a tool that doctors and nurses have likened to chatgpt for medicine, plans to announce a $200 million raise at a $6 billion valuation, the new york times reports.
Openevidence, valued at $6 billion, was founded in cambridge by a harvard grad. The leading medical information platform. Openevidence secures $200 million at $6b valuation to provide verified ai insights for clinicians, helping doctors make evidenced decisions.
